Snakebite asv protocol

Reading Document
Medical Text Search

snakebite antivenom ASV protocol indications dosing administration

Medical Text Search

snakebite management clinical features envenomation treatment

GradeResponse
GradeResponse
Here is a comprehensive overview of the Snakebite Anti-Snake Venom (ASV) Protocol, incorporating standard WHO/Indian national guidelines and Harrison's principles:

Snakebite ASV Protocol


1. Initial Assessment

History

  • Time of bite, snake description (color, size, hood/rattle)
  • Symptoms onset: local vs. systemic

Examination — Identify Envenomation Syndrome

SyndromeCommon SnakesFeatures
Cytotoxic/LocalVipers (Russell's, Saw-scaled)Swelling, necrosis, pain, blistering
HaemotoxicRussell's viper, Saw-scaled viperBleeding gums, hematuria, 20WBCT positive, coagulopathy
NeurotoxicKrait, CobraPtosis, ophthalmoplegia, bulbar palsy, respiratory failure
MyotoxicSea snakesMyalgia, myoglobinuria, rhabdomyolysis

2. Indications for ASV

ASV should be given only when there is evidence of systemic envenomation (Harrison's, p. 13049). Do NOT give prophylactically.

Definite Indications:

  • Haematotoxicity: 20-minute whole blood clotting test (20WBCT) positive; spontaneous bleeding (gum, IV site, hematuria); thrombocytopenia
  • Neurotoxicity: Ptosis, ophthalmoplegia, dysarthria, dysphagia, respiratory distress
  • Cardiovascular: Hypotension, shock, abnormal ECG
  • Renal: Oliguria/anuria, rising creatinine
  • Local envenomation (severe): Rapidly progressive swelling involving >50% of limb, necrosis, finger/toe bites with any swelling
Note: A dry bite (no envenomation) does NOT require ASV. Local swelling alone (without progression) is a relative indication.

3. 20-Minute Whole Blood Clotting Test (20WBCT)

  1. Place 2 mL fresh blood in a clean, dry glass tube
  2. Leave undisturbed for 20 minutes at room temperature
  3. Normal: Blood clots (tube can be tilted/inverted without spillage)
  4. Abnormal (Venom-Induced Consumption Coagulopathy, VICC): Blood remains liquid → ASV indicated
  5. Repeat every 6 hours during monitoring

4. ASV Administration

Antivenom Type

  • India: Polyvalent ASV — covers Big Four: Russell's viper, Saw-scaled viper, Common krait, Indian cobra
  • Produced from horse serum (IgG/F(ab')₂ fragments)
  • Monospecific ASV if offending species clearly identified (Harrison's, p. 13049)

Route

  • IV only (intramuscular is NOT recommended — unreliable absorption)

Preparation

  • Dilute ASV in 100–250 mL normal saline (0.9% NS)

Dosing

PresentationInitial Dose
Neurotoxic envenomation10 vials IV
Haemotoxic envenomation10 vials IV
Mixed/severe10–20 vials IV
  • Infuse slowly over 30–60 minutes (first 10–15 min at slow rate, monitoring for reactions)
  • Repeat dose: Give additional 10 vials if:
    • No clinical improvement after 1–2 hours
    • 20WBCT still positive at 6 hours
    • Neurotoxic signs progress
There is no maximum total dose — give as many vials as needed to achieve clinical neutralization.

Pediatric Dosing

  • Same dose as adults (venom dose is independent of patient body weight)

5. Pre-medication (Controversial)

Some guidelines (India's NHP) recommend prophylactic pre-medication to reduce anaphylaxis risk:
DrugDoseRoute
Adrenaline (epinephrine) 1:10000.25 mg (adult) / 0.01 mg/kg (child)SC, 15 min before ASV
Promethazine25 mg adult / 0.5 mg/kg childIV/IM
Hydrocortisone100–200 mgIV
WHO 2010 does not routinely recommend prophylaxis due to lack of evidence; have adrenaline drawn up and ready at all times.

6. Monitoring for Antivenom Reactions

Early Anaphylactic Reaction (within 10–180 min)

  • Urticaria, pruritus, fever, hypotension, bronchospasm
  • Action: Stop ASV infusion → Adrenaline 0.5 mg IM → Antihistamine + hydrocortisone IV → Resume at slower rate once stabilized

Pyrogenic Reaction (within 1–2 hours)

  • Fever, chills, rigors
  • Action: Paracetamol; cool with tepid sponging

Serum Sickness (5–14 days later)

  • Fever, rash, arthralgia, lymphadenopathy
  • Action: Oral prednisolone 5 mg every 6 hours × 5–7 days; antihistamines

7. Adjunct Management

Neurotoxic Bites (Krait/Cobra)

  • Neostigmine test: 1.5–2 mg neostigmine IM + 0.6 mg atropine IV — if improvement in ptosis within 30 min → continue neostigmine 0.5 mg every 30 min
  • Monitor respiratory rate, SpO₂; early intubation if VC <15 mL/kg or SpO₂ falling
  • Mechanical ventilation may be needed for days to weeks (krait bites)

Haemotoxic Bites

  • Fresh frozen plasma (FFP) or fresh whole blood if bleeding uncontrolled and ASV already given
  • Do NOT give FFP before ASV — it will be consumed by ongoing coagulopathy
  • Platelet transfusion only if active bleeding + severe thrombocytopenia

Local Wound Care

  • Clean with antiseptic; immobilize and keep below heart level
  • Tetanus prophylaxis
  • Antibiotics (amoxicillin-clavulanate or ciprofloxacin) only if signs of secondary infection
  • Fasciotomy: Only if confirmed compartment syndrome (not just swelling); measure compartment pressure >30 mmHg

Renal Failure

  • IV fluids to maintain urine output >0.5 mL/kg/hr
  • Dialysis if oliguria persists despite ASV and fluids

8. Monitoring Schedule

TimeAction
0 minBaseline vitals, 20WBCT, CBC, BUN/Cr, LFT, urine
30 minMonitor for anaphylaxis during infusion
1–2 hrReassess clinical response
6 hrRepeat 20WBCT; repeat ASV if still positive
12 hrRepeat labs
24 hrReassess, repeat 20WBCT
DailyContinue until 20WBCT normal ×2, neurotoxic signs resolving

9. What NOT to Do

  • ❌ Tourniquet (causes ischemia, worsens necrosis)
  • ❌ Incision and suction of bite site
  • ❌ Ice application
  • ❌ Electric shock therapy
  • ❌ Pressure immobilization for cytotoxic/hemotoxic bites
  • ❌ Intramuscular ASV
  • ❌ ASV without confirmed envenomation
Pressure immobilization bandage is appropriate ONLY for neurotoxic bites (krait, cobra, sea snake) where local effects are minimal.

10. Discharge Criteria

  • 20WBCT normal on ≥2 consecutive tests
  • No neurotoxic signs for 24 hours
  • Urine output normal, creatinine trending down
  • Local swelling stable/decreasing
  • Minimum observation: 24 hours after last ASV dose

Sources: Harrison's Principles of Internal Medicine, 21st Edition (p. 13049); WHO Guidelines for the Management of Snakebite, 2nd ed.; India National Health Program Snakebite Management Protocol.
This is a shared conversation. Sign in to Orris to start your own chat.